CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(03): 355-361
DOI: 10.1055/s-0042-1742633
Case Report

Primary Cutaneous Aspergillosis in an Immunocompetent Patient: A Case Report from a Tertiary Care Hospital in Chennai

Sathyakamala Ravichandran
1   Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India
,
Priyadarshini Shanmugam
1   Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India
,
Ambujavalli Balakrishnan Thayikkannu
1   Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India
,
Pradeep Elangovan
2   Department of Orthopaedics, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India
› Author Affiliations
Funding None.

Abstract

Aspergillosis is a systemic fungal infection that commonly affects immunocompromised individuals and, less frequently, immunocompetent individuals. It is the most common opportunistic fungal disease after candidiasis. This is primarily a pulmonary infection and can also involve other body sites like paranasal sinuses and cutaneous tissues. Aspergillus fumigatus, Aspergillus niger, and Aspergillus flavus are the common species infecting humans. Primary cutaneous aspergillosis (PCA) is usually caused by A. flavus and A. fumigatus. It is commonly seen in immunocompromised patients such as those suffering from diabetes, malignancies, tuberculosis, human immunodeficiency virus, or patients on long-term steroids and antibiotics. In this article, we report a case of PCA, in the immediate postoperative period, following a road traffic accident, in an immunocompetent patient. This posed a diagnostic challenge to the treating physicians. A. flavus was confirmed with 10% potassium hydroxide mount, lactophenol cotton blue, and growth on Sabouraud dextrose agar from tissue culture sample. Antifungal treatment was initiated with oral itraconazole 200 mg after performing antifungal susceptibility testing based on Clinical and Laboratory Standards Institute guidelines. The patient's condition improved and was discharged. Thus, early detection of PCA combined with medical and surgical intervention can successfully eradicate infection and help in preventing disseminated aspergillosis.

Authors' Contribution

SR, AB, and PS collected and analyzed the data. SR and AB prepared the manuscript and it was reviewed and modifications were made by PS. SR participated in the manuscript revision under the guidance of AB and PS. All authors of the manuscript gave their complete approval.




Publication History

Article published online:
15 February 2022

© 2022. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Chander J. Textbook of Medical Mycology. 4th edition.. New Delhi: Jaypee Brothers; 2018: 524-553
  • 2 Tahir C, Garbati M, Nggada HA, Yawe EH, Abubakar AM. Primary cutaneous aspergillosis in an immunocompetent patient. J Surg Tech Case Rep 2011; 3 (02) 94-96
  • 3 Bagate A, Birare S, Jadhav DS, Nalpe V, Patekar D. Cutaneous aspergillosis in an immunocompetent patient: a case report. Tropical Journal of Pathology and Microbiology 2020; 6 (02) 205-209 DOI: 10.17511/jopm.2020.i02.14.
  • 4 Zhang T, Christopher M, Simske NM, Saddler CM, Keenan T, Whiting PS. Fracture treatment in the setting of cutaneous aspergillosis: a case report. OTA Int 2020; 3 (03) e082 DOI: 10.1097/OI9.0000000000000082. PMID: 33937705; PMCID: PMC8023117
  • 5 Khatri ML, Stefanato CM, Benghazeil M, Shafi M, Kubba A, Bhawan J. Cutaneous and paranasal aspergillosis in an immunocompetent patient. Int J Dermatol 2000; 39 (11) 853-856
  • 6 Mohapatra S, Xess I, Swetha JV. et al. Primary cutaneous aspergillosis due to Aspergillus niger in an immunocompetent patient. Indian J Med Microbiol 2009; 27 (04) 367-370
  • 7 Chakrabarti A, Gupta V, Biswas G, Kumar B, Sakhuja VK. Primary cutaneous aspergillosis: our experience in 10 years. J Infect 1998; 37 (01) 24-27
  • 8 Camus M, Anyfantakis V, Dammak A, Riche A, Delouane H, Roblot F, Guillet G. Aspergillose cutanée primitive chez un agriculteur immunocompétent [Primary cutaneous aspergillosis in an immunocompetent farmworker]. Ann Dermatol Venereol 2010; 137 (05) 373-376 DOI: 10.1016/j.annder.2010.03.006. Epub 2010 Apr 24. PMID: 20470919.
  • 9 Avkan-Oğuz V, Çelik M, Satoglu IS, Ergon MC, Açan AE. Primary cutaneous Aspergillosis in immunocompetent adults: three cases and a review of the literature. Cureus 2020; 12 (01) e6600 DOI: 10.7759/cureus.6600.
  • 10 Neki N, Singh A, Shergill G, Sidhu P, Pannu J, Singh T. Cutaneous Aspergillosis in an immunocompetent patient. Int J Med Health Res 2016; 2: 57-58
  • 11 Sharma S, Yenigalla BM, Naidu SK, Pidakala P. Primary cutaneous aspergillosis due to Aspergillus tamarii in an immunocompetent host. BMJ Case Rep 2013; 2013: 010128 DOI: 10.1136/bcr-2013-010128.
  • 12 Chong YS, Ro BI. Cutaneous aspergillosis. Korean J Med Mycol 2002; 7 (01) 6-13
  • 13 Granstein RD, First LR, Sober AJ. Primary cutaneous aspergillosis in a premature neonate. Br J Dermatol 1980; 103 (06) 681-684
  • 14 Venugopal TV, Venugopal PV. Primary cutaneous aspergillosis from Tamil Nadu diagnosed by fine needle aspiration cytology. Med Mycol Case Rep 2012; 1 (01) 103-106
  • 15 Liu X, Yang J, Ma W. Primary cutaneous aspergillosis caused by Aspergillus fumigatus in an immunocompetent patient: a case report. Medicine (Baltimore) 2017; 96 (48) e8916 DOI: 10.1097/MD.0000000000008916.